Tyrosinase-IN-31
Product Specifications
UNSPSC Description
Tyrosinase-IN-31 (compound 2-06) is a central-targeting tyrosinase inhibitor (tyrosinase: monophenolase IC50=70.44 μM, diphenolase IC50=1.89 μM). Tyrosinase-IN-31 can inhibit the tyrosinase and melanogenesis. Tyrosinase-IN-31 can penetrate the BBB and enter the central nervous system (CNS). Tyrosinase-IN-31 shows neuroprotective effects and Parkinsonism behavior improving function[1].
Target Antigen
Tyrosinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tyrosinase-in-31.html
Smiles
O=C(N1CC(C=C(OC)C(OC)=C2)=C2CC1)CSC3=NC4=C(N3)C=CC=C4
Molecular Weight
383.46
References & Citations
[1]Qi S, et al. A new strategy for the treatment of Parkinson's disease: Discovery and bio-evaluation of the first central-targeting tyrosinase inhibitor. Bioorg Chem. 2024 Sep;150:107612.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161846/Tyrosinase-IN-31-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161846/
Clinical Information
No Development Reported
CAS Number
903206-81-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items